Is ABSI a good stock to buy? We came across a bullish thesis on Absci Corporation on TradersPro's Substack. In this article, we will summarize the bulls' thesis on ABSI. Absci Corporation's share was trading at $7.27 as of June 15th.
Pressmaster/Shutterstock.com
Absci Corporation (ABSI) is a clinical-stage biopharmaceutical company focused on transforming drug discovery through the use of generative artificial intelligence, positioning itself at the forefront of a rapidly growing trend toward AI-enabled drug development. The company's lead program, ABS-201, is an antibody-based therapy designed to treat androgenetic alopecia, or pattern hair loss, by targeting a protein pathway involved in hair follicle biology.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential

Around 77 million Americans hold gym memberships, according to the 2025 US Health & Fitness Consumer Report (1). With gyms charging average monthly dues of $65 (2), Americans are spending a lot of money to stay in shape.
But what happens if your gym membership is no longer worth it, you want to cancel, and your gym doesn't cooperate? Let's pretend, for example, that Xavier has a gym membership he signed up for two years ago. The membership is month-to-month, so he has the right to cancel, and he wants to do so.
Robert Kiyosaki says this 1 ****** et will surge 400% in a year and begs investors not to miss this 'explosion'
Millionaires under 43 hold only 25% of their wealth in stocks. Surprised? Here's where their money is actually going
Jeff Bezos backs a platform that lets anyone invest in rental homes for as little as $100 — here are 5 ways to build wealth like a landlord without actually being one